Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

Oxycodone is the active ingredient of recently bankrupted Purdue Pharma’s OxyContin, a drug which had taken much of the brunt of blame for the opioid addiction epidemic in the US. ... abuse. A number of pharma companies in the US have recently faced

Latest news

More from news
Approximately 7 fully matching, plus 732 partially matching documents found.

Latest Intelligence

  • The 2019 CPhI Pharma Index Report The 2019 CPhI Pharma Index Report

    Examining this year’s industry performance. The CPhI Pharma Industry rankings report returns for 2019, providing vital insight into the performance of the main pharmaceutical markets across the globe. ... us to see whether pharma has advanced or

  • The fight for affordable insulin The fight for affordable insulin

    Activists are organised, and demanding action on US insulin prices - and pointing the finger at pharma. ... Elizabeth Pfiester (second left) and fellow protesters. The last few years have seen the T1International movement spread from state to state

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... NHS England accusing Vertex of being an“extreme outlier” and

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... AstraZeneca is just one of several multinational pharma companies working with China’s homegrown tech companies.

More from intelligence
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest from PMHub

  • eyeforpharma Marketing and Customer Innovation Europe

    HCPs are human. What a basic assumption! But one that strangely people forget within pharma. ... It was reaffirming for us at Four Health to hear Pharma colleagues admit this oversight, and call for change in how we communicate with this key audience as

  • Digital Pharma Advances: Meet us in London

    Meet us in London at The Digital Pharma Advances Conference, January 30th, where Anthill will be presenting on the topic of digital transformation. ... At Anthill, we believe in a rapidly transforming digital world. One that, for every challenge, equally

  • A New Managing Director Appointed for Lighthouse Medical Communications US

    Dennis O’Brien (Lucid CEO and Co-Founder) commented, “Andy is a great fit with the team – and his history and experience in US and Global Pharma communications, both agency and ... client side, made him the ideal choice to head the Lighthouse

  • Creative effectiveness: how to achieve tangible results

    Advertising provides us with so much opportunity to create, to inspire, and to delight. ... What drives us at Blue Latitude Health is the opportunity to make a commercial difference.

  • Find your match in digital pharma marketing

    Aggressive? Cheeky? Genius? Geo-location targeting in pharma marketing is an absolute must. ... With the regional intricacies of EMEA and US pharma compliance, every pharma marketer knows their ABPI from their FDA, their PAGB from their EMA.

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics